Materialise Stock Price, News & Analysis

Materialise NV (MTLS) is a Belgium-headquartered company that focuses on 3D printing, also known as additive manufacturing. According to company disclosures and regulatory filings, Materialise incorporates more than three decades of 3D printing experience into a range of software solutions and 3D printing services that support sustainable 3D printing applications across multiple industries. The company’s shares trade on Nasdaq in the form of American depositary shares (ADSs) representing ordinary shares, and its ordinary shares are additionally listed on Euronext Brussels.

Business model and segments

Based on its public descriptions and financial reporting, Materialise structures its activities around software and services that enable industrial and medical use of 3D printing. The company’s products and services are organized in three segments:

• Materialise Medical – develops and delivers medical software solutions, medical devices, and other related products and services.
• Materialise Software – develops and delivers additive manufacturing software solutions and related services.
• Materialise Manufacturing – delivers 3D-printed products and related services.

These segments are reported separately in the company’s financial statements and are referenced in its quarterly results, highlighting their role in the overall business model.

Industry focus and applications

Materialise describes itself as a global leader in 3D‑printed medical devices and software and as a pioneer in additive manufacturing software and services. Its open, secure, and flexible end‑to‑end solutions are used for industrial manufacturing and mass personalization in a variety of industries. Company communications list healthcare, automotive, aerospace, eyewear, art and design, wearables, and consumer goods among the sectors where its software and 3D printing services are applied.

The company states that its solutions empower sustainable 3D printing applications. This focus on sustainability is reflected in references to sustainability reporting and in the way Materialise positions its technology as part of a move toward more efficient and responsible manufacturing.

Technology and capabilities

Materialise emphasizes the combination of a large software development organization with extensive in‑house 3D printing capacity. Public descriptions note that Materialise has the largest group of software developers in the 3D printing industry and operates one of the world’s largest and most complete 3D printing facilities. This combination underpins its role in both providing software that runs additive manufacturing workflows and offering manufacturing services that use those tools in practice.

The company’s software and services are described as open and secure, and as end‑to‑end solutions that support the full chain of 3D printing applications, from design preparation to production. In the medical field, Materialise Medical is highlighted in financial reports as a distinct segment, with recurring references to its revenue performance, indicating its importance within the overall group.

Geographic footprint and listings

Materialise is headquartered in Belgium and describes itself as having branches worldwide. In its earlier corporate profile, the company identified geographical segments including the United States, the Americas (excluding the USA), Belgium, Germany, France, Switzerland, the United Kingdom, Italy, the Netherlands, other European countries, and the Asia Pacific region. This reflects a broad international footprint in both software and manufacturing activities.

From a capital markets perspective, Materialise’s ADSs are listed on Nasdaq under the symbol MTLS. In addition, the company has obtained an additional listing of its ordinary shares on Euronext Brussels, with trading on that regulated market commencing on November 20, 2025. Company filings explain that this additional listing is intended to complement the existing Nasdaq listing and broaden the investor base, while no new capital was raised in connection with the Euronext Brussels admission.

Financial reporting and segment performance

Materialise reports its results under International Financial Reporting Standards (IFRS) and provides segment information for Materialise Medical, Materialise Software, and Materialise Manufacturing. In multiple quarterly reports, the company discusses revenue and profitability by segment, as well as consolidated metrics such as gross profit, operating result, and net profit. The company also discloses non‑IFRS measures such as EBIT, EBITDA, Adjusted EBIT, and Adjusted EBITDA, and explains how these are calculated and used in evaluating performance.

Across recent quarters, company commentary has highlighted the growth of the Materialise Medical segment, while also noting macro‑economic and geo‑political headwinds affecting the Manufacturing and Software segments. Management has referred to targeted cost control measures and structural efficiencies aimed at protecting operational profitability while maintaining research and development investments, particularly in medical activities.

Corporate governance and shareholder structure

Materialise communicates regularly with shareholders through annual and extraordinary general shareholders’ meetings. In 2025, the company convened extraordinary meetings to approve changes to its articles of association, including authorizations related to share buybacks, amendments linked to a potential ADS buyback program, and the introduction of double voting rights for certain shares. Following the admission of its shares to trading on Euronext Brussels, the company disclosed information on its total capital, number of securities carrying voting rights, total voting rights, and subscription rights.

The company has also outlined how Belgian transparency rules apply to significant shareholdings, specifying thresholds at which investors must notify the company and the Belgian Financial Services and Markets Authority (FSMA) when their voting rights cross certain percentages of the total.

Strategic initiatives and capital markets actions

In addition to its operational focus on additive manufacturing software and services, Materialise has pursued capital markets initiatives. The company announced and then completed an additional listing of its ordinary shares on Euronext Brussels. It has also announced an up to EUR 30 million ADS buyback program over Nasdaq, subject to shareholder authorization and completion of the Euronext Brussels listing, with the intention to execute repurchases within a defined period and potentially hold repurchased ADSs or underlying shares in treasury for uses such as mergers and acquisitions or equity incentive plans, in line with its stated growth ambitions in sectors such as healthcare, aerospace, and defense.

Position within the 3D printing ecosystem

Within the broader 3D printing and additive manufacturing ecosystem, Materialise presents itself as both a software publisher and a manufacturing service provider. Its long history in 3D printing, combined with its software development capabilities and large‑scale 3D printing facilities, positions the company as a central player in enabling industrial manufacturing and mass personalization. By serving industries such as healthcare, automotive, aerospace, eyewear, art and design, wearables, and consumer goods, Materialise connects digital design and production technologies with end‑user applications that rely on precise, repeatable additive manufacturing processes.

FAQs about Materialise NV (MTLS)

• What does Materialise NV do?
  

  Materialise NV develops and delivers additive manufacturing software solutions and 3D printing services. Its activities include medical software and devices, additive manufacturing software, and the production of 3D‑printed products through its Manufacturing segment.

• How is Materialise’s business organized?
  

  The company organizes its products and services into three segments: Materialise Medical, Materialise Software, and Materialise Manufacturing. These segments are reported separately in its financial statements and are referenced in its earnings releases.

• In which industries are Materialise’s solutions used?
  

  According to company descriptions, Materialise’s software and 3D printing services are used in industries including healthcare, automotive, aerospace, eyewear, art and design, wearables, and consumer goods, supporting industrial manufacturing and mass personalization.

• Where is Materialise headquartered?
  

  Materialise states that it is headquartered in Belgium and has branches worldwide. Its principal executive office address in Leuven, Belgium, is disclosed in its SEC filings.

• On which exchanges is Materialise listed?
  

  Materialise’s American depositary shares (ADSs) representing ordinary shares are listed on Nasdaq under the symbol MTLS. In addition, its ordinary shares have an additional listing on Euronext Brussels, where trading commenced on November 20, 2025.

• What are Materialise’s main business segments from a financial perspective?
  

  In its quarterly and half‑year financial reports, Materialise provides revenue and Adjusted EBITDA information for three segments: Materialise Medical, Materialise Software, and Materialise Manufacturing. These segments reflect the company’s focus on medical applications, software for additive manufacturing, and 3D printing production services.

• How does Materialise describe its role in the 3D printing industry?
  

  The company describes itself as a global leader in 3D‑printed medical devices and software and as a pioneer in additive manufacturing software and services. It emphasizes more than three decades of 3D printing experience and highlights that it combines the largest group of software developers in the industry with one of the world’s largest and most complete 3D printing facilities.

• What is the focus of the Materialise Medical segment?
  

  Materialise Medical develops and delivers medical software solutions, medical devices, and related products and services. Company financial reports repeatedly highlight the growth of this segment and its contribution to overall revenue and profitability.

• What is the purpose of Materialise’s additional listing on Euronext Brussels?
  

  Company announcements explain that the additional listing of ordinary shares on Euronext Brussels is intended to complement the existing Nasdaq listing of ADSs, broaden the investor base, and provide additional liquidity options for shareholders. No new shares were offered and no capital was raised in connection with the Euronext Brussels admission.

• Does Materialise have a share or ADS buyback program?
  

  Materialise has announced an up to EUR 30 million ADS buyback program over Nasdaq, subject to shareholder authorization and completion of the Euronext Brussels listing. The company has indicated that repurchased ADSs or underlying shares may be held in treasury and potentially used for mergers and acquisitions or equity incentive plans, in line with its growth strategy.